Lawyer for intellectual property: IP advice for life sciences, digital health and technology

Key takeaways

• A lawyer for intellectual property does not only help when disputes arise. Legal IP advice is often most valuable in IP strategy, contract drafting, licensing, due diligence and transactions. 

• In life sciences, biotech, pharma, MedTech and digital health, IP is often more than patents. It may also include know-how, data, software, trade secrets, trademarks, designs and regulatory documentation. 

• A clean chain of title is essential: who created which rights, who is allowed to use them and which rights need to be secured by contract? 

• IP lawyers and patent attorneys have different roles. Strong IP advice often requires technical patent strategy and legal commercialisation strategy to work together. 

• IP advice is particularly valuable when intellectual property is not treated in isolation, but together with financing, collaborations, software, data protection, clinical development and commercial exploitation. 

When do you need a lawyer for intellectual property?

A lawyer for intellectual property is relevant whenever intangible assets need to be protected, used, transferred, licensed or enforced.

In practice, the question is rarely limited to whether a patent, trademark or design can be registered. More often, the real question is commercial: how does a technology become an exploitable asset? Who may use research results? Which rights need to sit within the company? How should know-how be protected? Which IP risks will an investor or buyer identify in due diligence?

These questions are central in life sciences. Company value often exists long before first revenues are generated. It sits in IP rights, data, development information, software, regulatory documentation and contracts. If these components are not structured properly, companies can lose leverage in financing rounds, licensing deals, collaborations and exits.

What services does legal IP advice include?

Legal IP advice covers the structuring, protection, exploitation and enforcement of intellectual property.

Typical services include:

• developing and reviewing IP strategies 

• drafting and negotiating license agreements 

• patent assignments and IP assignment agreements 

• IP clauses in research, development and collaboration agreements 

• CDAs, MTAs, software agreements and data access agreements 

• advice on know-how, trade secrets and confidentiality 

• IP due diligence in financing rounds, M&A and carve-outs 

• reviewing chains of title involving founders, employees, universities, CROs, CDMOs and service providers 

• asserting and defending claims in IP disputes 

The individual agreement matters, but it is only one part of the structure. The broader IP set-up must fit the business model. A start-up will usually need different solutions from a pharmaceutical company, a spin-out different documentation from an established platform company and a license deal different mechanics from an asset deal.

What is the difference between a lawyer and a patent attorney?

Lawyers and patent attorneys often work together in intellectual property matters, but they have different roles.

A patent attorney is particularly important for technical IP strategy. This includes patent filings, drafting patent claims, handling prosecution before patent offices, oppositions against patents and the technical assessment of scope of protection, novelty and inventive step. This technical expertise is indispensable for active ingredients, diagnostics, platform technologies, manufacturing processes and MedTech inventions.

A lawyer for intellectual property focuses more on the legal and commercial exploitation of IP. This includes license agreements, IP transfers, research and development collaborations, CDAs, MTAs, software agreements, IP clauses, due diligence reviews, transactions and disputes around ownership, use rights or contractual breaches.

This distinction matters. A patent is only one part of the IP strategy. Once IP is embedded into contracts, collaborations, financing rounds, licensing deals or transactions, the analysis is no longer only about technical scope of protection. It also concerns liability, warranties, exclusivity, termination, sublicensing, data rights, know-how, antitrust, confidentiality, regulatory interfaces, change-of-control issues and later enforceability. These are classic legal advisory topics.

Just as lawyers without patent-technical specialisation should not draft patent claims or conduct freedom-to-operate analyses, complex license, collaboration or transaction agreements should not be approached solely from the perspective of patent prosecution. Strong IP advice does not mean that one profession replaces the other. It means that patent attorneys handle the technical protection-rights side and lawyers handle the legal and commercial exploitation side, with both perspectives aligned.

In life sciences, both perspectives are often needed. The patent attorney helps build and defend the technical right. The lawyer ensures that this right can be used commercially in contracts, collaborations, financing rounds, licensing deals and transactions.

Why is intellectual property particularly complex in life sciences?

Intellectual property is particularly complex in life sciences because technical development, data, regulation and commercial exploitation are closely connected.

A drug candidate, diagnostic method, digital health application or platform technology is rarely made up of a single IP right. Patents, know-how, data rights, software, study documents, regulatory dossiers, trademarks and trade secrets often interact.

There may also be several parties involved: founders, universities, research institutions, employees, consultants, CROs, CDMOs, industry partners and investors. This is why it should be clarified early which rights already exist, who owns them and whether they need to be transferred, licensed or made usable by contract.

That is also why IP advice in life sciences often overlaps with contract law, data protection, software, clinical trials, regulatory issues and transactions.

How does an intellectual property lawyer help with contracts?

An intellectual property lawyer ensures that contracts reflect the commercial IP logic of the relationship.

This is especially important when distinguishing between Background IP, Project IP, Improvements, data rights and usage rights. In simple projects, an IP clause may be short. In research collaborations, licensing deals or platform projects, it is often the economic core of the contract.

Important questions include:

Which IP does each party bring into the project? Who owns new results? Who may use data, software or know-how? Can results be further developed, sublicensed or used in other projects? What happens when the collaboration ends?

If these questions are left open, disputes often arise exactly where they become expensive: investor due diligence, licensing negotiations, strategic collaborations or exits.

What role does IP advice play in licensing and technology transfer?

In licensing and technology transfer, the goal is to make intellectual property commercially usable without unintentionally weakening the owner’s position.

A license agreement does not only answer whether a third party may use a technology. It defines the territory, indication, scope, duration and commercial consequences of that use. In life sciences, know-how, data, regulatory documentation, improvements, sublicenses, development obligations, milestones and royalties are also critical.

IP advice is also central in patent assignments, spin-outs and university or research institution transfers. The question is not only whether a right can be transferred. The key issues are whether the chain of title is complete, which existing licenses or encumbrances remain in place and whether the IP remains financeable in the new structure.

Why is IP due diligence important?

IP due diligence examines whether a company actually owns or can use the rights on which its value depends.

This is particularly important in financing rounds, M&A, carve-outs, licensing deals and strategic collaborations. Investors, buyers and licensees want to know whether the key IP rights exist, whether the right persons or entities own them, whether third parties have claims and whether the relevant contracts are sufficiently robust.

Typical review areas include patents, trademarks, designs, copyright, software, data rights, trade secrets, license agreements, employee and founder contributions, consultant agreements, collaboration agreements, publications, open-source use and existing encumbrances.

Companies should not wait until a transaction process starts to clarify these questions. Those who structure chain of title, contracts and documentation early can later negotiate faster and on better terms.

What should companies prepare before seeking legal IP advice?

Companies should first try to identify which asset needs to be protected or exploited.

It is helpful to prepare an initial overview of the following points:

1. Which IP rights, data, software, documents or know-how components exist? 

2. Who created them? 

3. Which contracts are already in place? 

4. Have materials or information been published or shared confidentially? 

5. Which third parties were involved? 

6. Is the asset meant to be financed, licensed, transferred, enforced or contributed to a collaboration? 

This preparation does not replace legal review. But it makes the advice faster, more precise and more commercially useful.

Conclusion

A lawyer for intellectual property should not only be involved once a dispute has arisen.

In life sciences, digital health and technology, much of the value is created when IP is structured properly from the beginning. Chain of title, confidentiality, contracts, licensability, data access, software and transaction readiness need to fit together. Companies that address these topics early do more than protect themselves against infringement. They create the legal foundation for financing, collaboration, licensing and exit.

This is not about putting legal and patent attorney advice against each other. The opposite is true. Complex life sciences projects benefit when technical patent strategy and legal exploitation strategy are aligned from the start.

Questions about a specific IP topic?

The authors behind BIO.LAW regularly support clients in practice on the topics discussed above, including IP strategy, licensing, IP transfers, research collaborations, CDAs, MTAs and due diligence issues in life sciences and digital health.

Contact: bio.law/getintouch